Cancer’s future may lie in combination therapy—pairing treatments to outsmart tumors, boost survival, and bring new hope ...

A new study led by researchers at the Icahn School of Medicine at Mount Sinai has found that adding the targeted therapy ...

Treatment for advanced bladder cancer had not significantly changed for 40 years. Now thousands are set to benefit ...

Being diagnosed with a disease like prostate cancer is a very impactful life event, making it vital to have people you love ...

Researchers found that adding a third immune-targeting drug to existing therapies helped shrink tumors in lab models of ...

A new study from Moffitt Cancer Center may offer a breakthrough for patients with advanced melanoma who don't respond to ...

Pfizer said on Tuesday its cancer drug Padcev, in combination with Merck's Keytruda, significantly improved survival rates in ...

Treating psoriatic arthritis (PsA) patients with more than one targeted therapy appears to be just fine, with no increased ...

In this video from the American Society of Retina Specialists annual meeting, Charles C. Wykoff, MD, PhD, FASRS, discusses ...

The review included a total of 16 publications, which were post hoc analyses (n=10), randomized controlled trials (n=5), and a cohort study (n=1). SGLT2 inhibitor and GLP-1RA combination therapy ...

The CAPS-5 total score ranks the severity of 20 PTSD symptoms from 0 (not present) to 80 (most severe). Baseline values for the combination and placebo groups, respectively, were 38.4 and 38.7 points.